Source: Endpoints News

Spotlight Therapeutics: Exclusive: CRISPR delivery startup Spotlight Therapeutics shuts down

Spotlight Therapeutics, a startup with a bold vision for delivering CRISPR therapies into the body without the need for viral vectors or lipid nanoparticles, has shut down, Endpoints News has learned. The San Francisco-based company ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Mary Haak-Frendscho's photo - President & CEO of Spotlight Therapeutics

President & CEO

Mary Haak-Frendscho

CEO Approval Rating

90/100

Read more